Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and we expect FY22 to be the low point in earnings, with FY23 and FY24 returning to double-digit EPS growth.
Posted on | by Leon Hinde
Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and we expect FY22 to be the low point in earnings, with FY23 and FY24 returning to double-digit EPS growth.
Or start a free thirty day trial for our full service, which includes our ASX Research.